Healthcare

By

Bret Jensen

 | Aug 18, 2014 | 12:30 PM EDT

There has been huge progress in treating this lethal disease.

By

Robert Moreno

 | Aug 14, 2014 | 1:58 PM EDT

Here's how I'd trade this biotech fund, Incyte and Immunogen.

By

Jim Cramer

 | Aug 14, 2014 | 12:18 PM EDT

Amgen's gain is pure insanity from a stock picker's point of view.

By

Sham Gad

 | Jul 28, 2014 | 12:00 PM EDT

Amid the basket's impressive performance, I'm adding Minerva.

By

Timothy Collins

 | Jul 22, 2014 | 1:05 PM EDT

The post-earnings trend says the stock will drop after the report.

By

Martin Tillier

 | Jul 17, 2014 | 5:00 PM EDT

What to do when central bankers tell you to cut risk.

By

Paul Price

 | Jul 17, 2014 | 10:00 AM EDT

A lower price means more value for this high-quality stock.

By

Ed Ponsi

 | Jul 16, 2014 | 12:00 PM EDT

There's a great entry point in Celgene at $84.

By

David Katz

 | Jul 11, 2014 | 7:30 AM EDT

It is preserving its Copaxone franchise, and the executive changes are good news.

By

Jim Cramer

 | Jul 10, 2014 | 5:35 AM EDT

Cheap money and greed from the Allergan bidder's side are strong incentives.

The major market indices continue to move within the parameters of the Fibonacci retraceme...
Since we cleared a key decision on the way up, I want to watch this pullback for an entry ...
Conclusion DDD is down today on new that the firm has cut revenue forecast due to producti...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.